RBC Capital Thinks KP Tissue’s Stock is Going to Recover

In a new note to investors today, an analyst has provided a rating update for the Consumer Goods sector company, KP Tissue (KPT). RBC Capital’s analyst Paul Quinn reiterates their Buy rating on the shares, with a C$10 price target.

According to TipRanks.com, Quinn is a top 100 analyst with an average return of 17.6% and a 68.0% success rate. Quinn covers the Consumer Goods sector, focusing on stocks such as International Paper Co, Clearwater Paper, and Resolute Forest.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for KP Tissue with a C$9.60 average price target, implying a 27.3% upside from current levels. In a report released yesterday, Scotiabank also reiterated a Buy rating on the stock with a C$10.50 price target.


Based on KP Tissue’s latest earnings release for the quarter ending June 30, the company reported a quarterly GAAP net loss of C$1.33 million. In comparison, last year the company had a GAAP net loss of C$70K.

KP Tissue, Inc. operates as a holding company engages in the production, distribution, marketing, and sale of products, including bathroom tissue, facial tissue, paper towels and napkins, for both the consumer and the away-from-home market. It operates through the following segments: Away-From-Home, Consumer, and Other. The Away-From-Home includes the Purex, Esteem, White Swan, Embassy, and Chalet brands. The Consumer segment operates through the following brands: Cashmere, Purex, Scotties, SpongeTowels, and White Cloud. The Other segment consists primarily of parent rolls sold to third parties in Canada and the United States through brokers. The company was founded in October 2012 and is headquartered in Mississauga, Canada.

The company’s shares closed on Friday at C$7.54, close to its 52-week low of C$6.58.